RPRX logo

Royalty Pharma (RPRX) Long term debt

Annual long term debt:

$6.61B+$479.37M(+7.81%)
December 31, 2024

Summary

  • As of today (May 21, 2025), RPRX annual long term debt is $6.61 billion, with the most recent change of +$479.37 million (+7.81%) on December 31, 2024.
  • During the last 3 years, RPRX annual long term debt has fallen by -$481.42 million (-6.78%).
  • RPRX annual long term debt is now -6.78% below its all-time high of $7.10 billion, reached on December 31, 2021.

Performance

RPRX Long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Quarterly long term debt:

$6.62B+$4.19M(+0.06%)
March 31, 2025

Summary

  • As of today (May 21, 2025), RPRX quarterly long term debt is $6.62 billion, with the most recent change of +$4.19 million (+0.06%) on March 31, 2025.
  • Over the past year, RPRX quarterly long term debt has increased by +$479.47 million (+7.81%).
  • RPRX quarterly long term debt is now -12.93% below its all-time high of $7.60 billion, reached on June 30, 2024.

Performance

RPRX Quarterly long term debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Long term debt Formula

Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt

RPRX Long term debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.8%+7.8%
3 y3 years-6.8%-6.8%
5 y5 years+11.1%+14.6%

RPRX Long term debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-6.8%+8.1%-12.9%+8.3%
5 y5-year-6.8%+13.7%-12.9%+15.5%
alltimeall time-6.8%+13.7%-12.9%+15.5%

RPRX Long term debt History

DateAnnualQuarterly
Mar 2025
-
$6.62B(+0.1%)
Dec 2024
$6.61B(+7.8%)
$6.61B(+0.1%)
Sep 2024
-
$6.61B(-13.0%)
Jun 2024
-
$7.60B(+23.8%)
Mar 2024
-
$6.14B(+0.1%)
Dec 2023
$6.14B(+0.3%)
$6.14B(+0.1%)
Sep 2023
-
$6.13B(+0.1%)
Jun 2023
-
$6.13B(+0.1%)
Mar 2023
-
$6.12B(+0.1%)
Dec 2022
$6.12B
$6.12B(+0.1%)
Sep 2022
-
$6.11B(-14.0%)
DateAnnualQuarterly
Jun 2022
-
$7.11B(+0.1%)
Mar 2022
-
$7.10B(+0.1%)
Dec 2021
$7.10B(+22.0%)
$7.10B(+0.1%)
Sep 2021
-
$7.09B(+21.7%)
Jun 2021
-
$5.83B(+0.1%)
Mar 2021
-
$5.82B(+0.1%)
Dec 2020
$5.82B(-2.3%)
$5.82B(+0.1%)
Sep 2020
-
$5.81B(+1.4%)
Jun 2020
-
$5.73B(-0.8%)
Mar 2020
-
$5.77B(-3.0%)
Dec 2019
$5.96B(-4.5%)
$5.96B
Dec 2018
$6.24B
-

FAQ

  • What is Royalty Pharma annual long term debt?
  • What is the all time high annual long term debt for Royalty Pharma?
  • What is Royalty Pharma annual long term debt year-on-year change?
  • What is Royalty Pharma quarterly long term debt?
  • What is the all time high quarterly long term debt for Royalty Pharma?
  • What is Royalty Pharma quarterly long term debt year-on-year change?

What is Royalty Pharma annual long term debt?

The current annual long term debt of RPRX is $6.61B

What is the all time high annual long term debt for Royalty Pharma?

Royalty Pharma all-time high annual long term debt is $7.10B

What is Royalty Pharma annual long term debt year-on-year change?

Over the past year, RPRX annual long term debt has changed by +$479.37M (+7.81%)

What is Royalty Pharma quarterly long term debt?

The current quarterly long term debt of RPRX is $6.62B

What is the all time high quarterly long term debt for Royalty Pharma?

Royalty Pharma all-time high quarterly long term debt is $7.60B

What is Royalty Pharma quarterly long term debt year-on-year change?

Over the past year, RPRX quarterly long term debt has changed by +$479.47M (+7.81%)
On this page